The BATURA trial ended early due to high efficacy data at pre-planned analysis. Topline results were announced from a phase 3b trial evaluating albuterol/budesonide metered dose inhaler in patients ...

A significant proportion of patients with asthma who received intermittent oral corticosteroids experienced a frequent prescribing pattern. Increasing frequent patterns of intermittent oral ...

Please provide your email address to receive an email when new articles are posted on . Adults with persistent asthma, but not those with intermittent asthma, have a higher carotid plaque burden ...

Please provide your email address to receive an email when new articles are posted on . Significantly fewer pediatric patients with low- vs. high-risk intermittent asthma had an ED visit and inhaled ...

Nov. 23 (UPI) --Adults with persistent asthma -- who use daily medication to control symptoms -- may be at increased risk of heart attack or stroke, as compared to people without this breathing ...

In many patients, annual short-acting beta2-agonist prescription fulfillment is indicative of uncontrolled disease and increased incidence of exacerbations. Credit: Getty Images. Short-acting beta ...

DALLAS, Nov. 23, 2022 — Adults with persistent asthma may be at increased risk of heart attack or stroke because of excess plaque buildup in the carotid arteries, according to new research published ...

An analysis of data from the Multi-Ethnic Study of Atherosclerosis suggests that adults with asthma may have higher levels of carotid artery plaque, which is associated with greater risk of heart ...

A 45-year-old woman presents with long-standing exertional dyspnea, wheezing, and intermittent dry cough, which has been ongoing for over the past 10 years.

The wheezing. The coughing. The extreme and sudden shortness of breath. These are symptoms that are attached to asthma, which is a surprisingly common condition. According to the Asthma and Allergy ...

Adolescents with overweight or obesity and asthma had a lower risk of asthma exacerbations after starting a GLP-1 receptor agonist, a retrospective cohort study found.